{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:10:41Z","timestamp":1779923441067,"version":"3.53.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jfma.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T08:12:30Z","timestamp":1679386350000},"page":"800-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals"],"prefix":"10.1016","volume":"122","author":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Sharng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Kun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheoi-Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-I","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-7941","authenticated-orcid":false,"given":"Tung-Hung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2507-9627","authenticated-orcid":false,"given":"Shang-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Hsuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2468-1253(19)30240-7","article-title":"Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study","volume":"4","author":"Bethea","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2018.05.039","article-title":"Sofosbuvir\/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients","volume":"69","author":"Agarwal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/hep.30046","article-title":"Glecaprevir\/pibrentasvir treatment in liver or kidney transplant patients with hepatitis C virus infection","volume":"68","author":"Reau","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/cid\/cix787","article-title":"Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection","volume":"66","author":"Liu","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.3390\/cancers13153694","article-title":"Five-year follow-pp of cured HCV patients under real-world interferon-free therapy","volume":"13","author":"Flisiak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jfma.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/jvh.12967","article-title":"Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy","volume":"25","author":"Hayashi","year":"2018","journal-title":"J Viral Hepat"},{"issue":"22","key":"10.1016\/j.jfma.2023.03.004_bib8","first-page":"S1542","article-title":"Long-term follow-up of hepatitis C patients who achieved sustained virologic response in the pragmatic PRIORITIZE study","author":"Lok","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/liv.15211","article-title":"Durability of sustained virological response to glecaprevir\/pibrentasvir and resistance development: a long-term follow-up study","volume":"42","author":"Poordad","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2023.03.004_bib10","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/liv.13652","article-title":"Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation","volume":"38","author":"Beinhardt","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jfma.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ekir.2021.11.022","article-title":"One-year outcomes of the multi-center study to transplant hepatitis C-infected kidneys (MYTHIC) trial","volume":"7","author":"Sise","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jfma.2023.03.004_bib12","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/JCM.03548-14","article-title":"Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping","volume":"53","author":"Liu","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jgh.13834","article-title":"A noninvasive diagnosis of hepatic fibrosis by BioFibroScore\u00ae in chronic hepatitis C patients","volume":"33","author":"Liu","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jfma.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/apt.16697","article-title":"Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment","volume":"55","author":"Liu","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jfma.2023.03.004_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac348","article-title":"Hepatitis C virus reinfection in people with HIV in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study","volume":"9","author":"Liu","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jfma.2023.03.004_bib16","first-page":"154","article-title":"Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: a concise review","volume":"15","author":"Burgess","year":"2016","journal-title":"Ann Hepatol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:49:22Z","timestamp":1760539762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0929664623000712"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.03.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}